MitoSense is an R&D company with exclusively licensed and patent pending technology that harnesses t
Location: United States, Massachusetts, Plymouth
Total raised: $3.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.01.2024 | Seed | $3.5M | - |
Mentions in press and media 3
| Date | Title | Description |
| 22.01.2024 | MitoSense Closes $3.5M in Seed Funding | MitoSense, a Plymouth, MA-based research and development company focused on neurodegenerative disease treatments, raised $3.5M in Seed funding. The round was led by Caydan Capital Partners. The company intends to use the funds to advance it... |
| 22.01.2024 | MitoSense Completes $3.5 Million Seed Funding | PLYMOUTH, MA, MitoSense, a biotechnology company, announced the close of its Series Seed Funding Round led by Caydan Capital Partners, raising close to $3.5 million. >> Click here for more funding data on MitoSense >> To exp... |
| - | Mitosense | “MitoSense is an R&D company with exclusively licensed and patent pending technology to replenish mitochondria to fight disease, including neurodegenerative disorders such as ALS, Alzheimer’s and Parkinson’s.” |